What is the market doing?
What the tape says about NVCR
NovoCure Limited is +39% over the past year while the S&P 500 is +20%: 19 points ahead of the market.
+39%
1-year return · S&P 500 +20%
- vs 200-day average
- +20%
vs 200-day average · a clear uptrend
- RSI (14)
- 45
RSI (14) · neutral
- Below its 52-week high
- 16%
Below its 52-week high
Details›
- Last close2026-09-08
- $16.86
- 1 monthS&P 500 −0.30%
- +7.6%
- 1 yearS&P 500 +20%
- +39%
- 5 yearsS&P 500 +85%
- −88%
- vs 50-day average$16.77
- +0.50%
- 52-week high
- $20.00
- 52-week low
- $10.03
- Annualised volatility
- 81%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$3.3M
| Year | Return |
|---|---|
| 2026 (year to date) | +30% |
| 2025 | −57% |
| 2024 | +100% |
| 2023 | −80% |
| 2022 | −2.3% |
| 2021 | −57% |
| 2020 | +105% |
| 2019 | +152% |
| 2018 | +66% |
| 2017 | +157% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +1.5% |
| Feb | 10 | 5 of 10 | +0.44% |
| Mar | 10 | 4 of 10 | −6.2% |
| Apr | 10 | 6 of 10 | +13% |
| May | 10 | 9 of 10 | +16% |
| Jun | 10 | 3 of 10 | −4.3% |
| Jul | 11 | 6 of 11 | +0.34% |
| Aug | 11 | 7 of 11 | +2.6% |
| Sep | 11 | 4 of 11 | −2.4% |
| Oct | 10 | 2 of 10 | −9.2% |
| Nov | 10 | 6 of 10 | +7.7% |
| Dec | 10 | 6 of 10 | +8.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.